Occupational Cancer Research Centre

Recent papers from Occupational Cancer Research Centre

1. Menopause and NeurologyNeurology Clinical Practice · 2026
2. Systems biology graphical notation: activity flow language level 1 version 1.3Berichte aus der medizinischen Informatik und Bioinformatik/Journal of integrative bioinformatics · 2026
3. Canadian National Pancreas Conference 2025: Recent Advances in Patient-Centred Management of Pancreatic CancerCurrent Oncology · 2026
4. Distinct clinical subtypes of genetic frontotemporal dementia identified using disease progression modellingBrain Communications · 2026
5. Exclusive and Any Breastfeeding, Infant Formula Feeding, and Childhood GrowthPEDIATRICS · 2026
6. Trends in Opioid‐Related Poisonings and Mental and Behavioral Disorders From 2006 to 2022 Among a Large Cohort of Injured Workers in Ontario, CanadaAmerican Journal of Industrial Medicine · 2026
7. Ancestry-Dependent Immunologic and Prognostic Effects Characterize the Prostate Cancer Urinary ProteomeJNCI Journal of the National Cancer Institute · 2026
8. Neurofibrillary tangle maturation in nodding syndrome of UgandaActa Neuropathologica Communications · 2026
9. Peripheral cytochrome P450-soluble epoxide hydrolase oxylipins and Alzheimer’s disease progressionTranslational Psychiatry · 2026
10. 52‐week ivarmacitinib in moderate‐to‐severe atopic dermatitis: A phase 3 trialJournal of the European Academy of Dermatology and Venereology · 2026
11. Associations of Plasma GDF15, CRP, and IL-6 With Cognitive Trajectories in Patients With Frontotemporal Lobar DegenerationNeurology Open Access · 2026
12. Diurnal Regulation of Hippocampal Synaptic Plasticity in Aged Rats and the Role of the Circadian Clock Gene Per1Hippocampus · 2026
13. 20 Updates on Magnetic Resonance Imaging assessment of tumour MicrOStructure in GlioblastomA: A cross-sectional study (The MIMOSA Study)Neuro-Oncology · 2026
14. Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trialThe Lancet · 2026
15. Cell‐Type‐Resolved Proteomics Reveals Distinct Immune and Metabolic Programs Between Primary and Recurrent Ascites in HGSOCPROTEOMICS - CLINICAL APPLICATIONS · 2026
16. Molecular characterization of mismatch repair deficient tumors in young Jordanian patientsDiscover Oncology · 2026
17. α‐Synuclein strain homogeneity in multiple system atrophy subtypesBrain Pathology · 2026
18. Evolving Trends in Laryngeal Cancer Mortality in the United States, 1999–2024: A Population‐Based Analysis With Subgroup Stratified Trends through 2020Asia-Pacific Journal of Clinical Oncology · 2026
19. ctDNA-derived copy-number signatures associated with immune checkpoint inhibitor resistance beyond PD-L1 and TMB in advanced NSCLCFrontiers in Oncology · 2026
20. Personalized Autologous Vaccines Activate Stimulator of Interferon Gene and Suppress Dendritic Cell Programmed Death Ligand 1 to Potentiate Antitumor ImmunityACS Nano · 2026